Furthermore, recent reports found that alpinetin bound to the cavity of R273H mutant p53 through mediately or directly impacting the DNA binding domain with a dissociation constant calculated to 75.11 μM, indicating that alpinetin may definitely salvage DNA-contact mutant p53 in tumor treatment (Malami et al., 2017b). Here, TP53 is linked to neoplasm.